Boston Scientific
1,064 hedge funds and large institutions have $71.5B invested in Boston Scientific in 2023 Q2 according to their latest regulatory filings, with 134 funds opening new positions, 400 increasing their positions, 358 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 994 → 1,064 (+70)
0.91% less ownership
Funds ownership: 91.35% → 90.45% (-0.91%)
9% less call options, than puts
Call options by funds: $295M | Put options by funds: $326M
Holders
1,064
Holding in Top 10
30
Calls
$295M
Puts
$326M
Top Buyers
| 1 | +$285M | |
| 2 | +$230M | |
| 3 | +$227M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$215M |
| 5 |
Amundi
Paris,
France
|
+$142M |
Top Sellers
| 1 | -$549M | |
| 2 | -$543M | |
| 3 | -$353M | |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$206M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$139M |